Peter Thiel

Portfolio · 1

Chemomab Therapeutics

Innovative Treatments for Patients with Fibro-Inflammatory-Related Diseases

3 rounds $75.5M committed Latest: 2021-03

Investment activity

1 portfolio exit on record.

Q&A

What is Peter Thiel's primary investment focus by sector?

Peter Thiel has a clear focus on the Health Tech & Life Sciences sector, with all of his portfolio companies and exits concentrated in this area.

Can you name a notable exit for Peter Thiel?

Peter Thiel saw an exit in March 2021 when Chemomab Therapeutics completed a Reverse Merger Event and began trading on NASDAQ.

What is one of Peter Thiel's portfolio companies?

One of Peter Thiel's portfolio companies is Chemomab Therapeutics, which focuses on innovative treatments for fibro-inflammatory-related diseases.

What is Peter Thiel's investment stage preference?

Peter Thiel has participated in various funding stages, including a B Round, a C Round, and a PIPE round.

When was Peter Thiel's most recent investment activity?

Peter Thiel's most recent recorded investment activity was in March 2021.

What is the total amount of capital raised by Chemomab Therapeutics, a company in Peter Thiel's portfolio?

Chemomab Therapeutics has raised $90.5M in total capital.